ACARIZAX® approved in Canada for treatment of young children
ALK (ALKB:DC / OMX: ALK B) today announced that Health Canada has approved ALK’s ACARIZAX® tablet for use in children,...
ALK (ALKB:DC / OMX: ALK B) today announced that Health Canada has approved ALK’s ACARIZAX® tablet for use in children,...
SEATTLE and VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
THE WOODLANDS, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will...
Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support...
Ping An ranks first in global patents in healthcare and fintech, according to two new reports from the Intellectual Property...
NASHVILLE, Tenn., March 6, 2025 /PRNewswire/ -- SLD Technology, a major sponsor, in collaboration with the Association of Medical Facility...